Furthermore, we provide evidence that SPARC exerts a tumour-suppressor effect in OvCa linking inflammation to metabolic programming, a process termed “metaflammation” that has been implicated in diseases associated with inflammation and perturbed bioenergetics as diabetes, obesity and aging [52]. This evidence concerns the gene SPARC and obesity due to melanocortin 4 receptor deficiency.